KTTA•benzinga•
Pasithea Therapeutics Announces Pricing Of $5M Public Offering Of 3,571,428 Shares Of Common Stock And Accompanying Series C Warrants To Purchase Up To 3,571,428 Shares Of Common Stock And Series D Warrants To Purchase Up To 3,571,428 Shares Of Common Sto
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 6, 2025 by benzinga